Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Randomized, Open-Label, Phase III Study of Nivolumab (BMS-936558) vs. Everolimus in Subjects with Advanced or Metastatic Clear Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy.
Open to Accrual
Chemotherapy: Systemic, Immunotherapy
Defintions of terms and FAQ about clinical trials.
David Quinn, M.D.
Other Trial Staff:
Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Roberto Tejada, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.